Use of zoledronic acid reduces a long-term risk for skeletal complications in patients with cancer of the kidney or urinary bladder

Use of zoledronic acid reduces a long-term risk for skeletal complications in patients with cancer of the kidney or urinary bladder

.

Bibliographic Details
Main Authors: P. F. Mulders, K. Miller, N. S. Tchekmedyian
Format: Article
Language:Russian
Published: ABV-press 2020-02-01
Series:Onkourologiâ
Online Access:https://oncourology.abvpress.ru/oncur/article/view/1046
id doaj-1d50b67f427e46afac4af95383486be7
record_format Article
spelling doaj-1d50b67f427e46afac4af95383486be72021-07-29T08:41:44ZrusABV-pressOnkourologiâ 1726-97761996-18122020-02-014110.17650/1726-9776-2008-4-1-55929Use of zoledronic acid reduces a long-term risk for skeletal complications in patients with cancer of the kidney or urinary bladderP. F. Mulders0K. Miller1N. S. Tchekmedyian2University Hospital NijmegenUniversitatsklinikum Benjamin FranklinPacific Shores Medical Group.https://oncourology.abvpress.ru/oncur/article/view/1046
collection DOAJ
language Russian
format Article
sources DOAJ
author P. F. Mulders
K. Miller
N. S. Tchekmedyian
spellingShingle P. F. Mulders
K. Miller
N. S. Tchekmedyian
Use of zoledronic acid reduces a long-term risk for skeletal complications in patients with cancer of the kidney or urinary bladder
Onkourologiâ
author_facet P. F. Mulders
K. Miller
N. S. Tchekmedyian
author_sort P. F. Mulders
title Use of zoledronic acid reduces a long-term risk for skeletal complications in patients with cancer of the kidney or urinary bladder
title_short Use of zoledronic acid reduces a long-term risk for skeletal complications in patients with cancer of the kidney or urinary bladder
title_full Use of zoledronic acid reduces a long-term risk for skeletal complications in patients with cancer of the kidney or urinary bladder
title_fullStr Use of zoledronic acid reduces a long-term risk for skeletal complications in patients with cancer of the kidney or urinary bladder
title_full_unstemmed Use of zoledronic acid reduces a long-term risk for skeletal complications in patients with cancer of the kidney or urinary bladder
title_sort use of zoledronic acid reduces a long-term risk for skeletal complications in patients with cancer of the kidney or urinary bladder
publisher ABV-press
series Onkourologiâ
issn 1726-9776
1996-1812
publishDate 2020-02-01
description .
url https://oncourology.abvpress.ru/oncur/article/view/1046
work_keys_str_mv AT pfmulders useofzoledronicacidreducesalongtermriskforskeletalcomplicationsinpatientswithcancerofthekidneyorurinarybladder
AT kmiller useofzoledronicacidreducesalongtermriskforskeletalcomplicationsinpatientswithcancerofthekidneyorurinarybladder
AT nstchekmedyian useofzoledronicacidreducesalongtermriskforskeletalcomplicationsinpatientswithcancerofthekidneyorurinarybladder
_version_ 1721252439221338112

Similar Items